Research by Design, LLC | Chicago, IL

Research site

Location

10801 South Western Avenue, Suite 201, Chicago, Illinois, United States of America

Site insights

Top conditions

Top treatments

BI 685509

Relmapirazin

MB-102

Calcifediol

PF-07321332

Ritonavir

Finerenone

MK-8527-008

CTAP101

sodium chloride

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Research by Design

Verified by this site

Active trials

5 of 33 total trials

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

The purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease.

Enrolling

Proteinuric Kidney Disease

Drug: MZE829

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study designed to evaluate the efficacy and safety of praliciguat in adu...

Enrolling

Focal Segmental Glomerulosclerosis

Drug: Praliciguat

Other: Placebo

A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

The purpose of this study is is to evaluate the efficacy and safety of veverimer in treating adults with moderate-to-severe chronic kidney disease (C...

Enrolling

CKD

Metabolic Acidosis

Drug: Placebo

Drug: Veverimer

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

This study will evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses (SAD) and multiple ascendin...

Enrolling

Chronic Kidney Disease

Drug: Placebo

Drug: AZD4248

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease (ANCHOR-POC)

This study is researching an experimental drug called ALN-ANG3 (called "study drug"). The study is focused on participants who have diabetic kidney d...

Enrolling

Diabetic Kidney Disease (DKD)

Drug: Evinacumab

Drug: ALN-ANG3